HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$25.18
Day range
$24.27 - $25.28
Year range
$23.77 - $59.91
Market cap
3.03B USD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 212.53M | 45.19% |
Operating expense | 121.48M | -14.27% |
Net income | -36.35M | 58.96% |
Net profit margin | -17.11 | 71.72% |
Earnings per share | -0.29 | 60.27% |
EBITDA | -25.72M | 69.40% |
Effective tax rate | -0.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 416.14M | 17.04% |
Total assets | 885.05M | 12.21% |
Total liabilities | 656.51M | 10.49% |
Total equity | 228.54M | — |
Shares outstanding | 125.52M | — |
Price to book | 13.68 | — |
Return on assets | -7.32% | — |
Return on capital | -9.30% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -36.35M | 58.96% |
Cash from operations | 19.36M | 119.78% |
Cash from investing | -20.00K | -600.00% |
Cash from financing | -4.00M | -2.22% |
Net change in cash | 14.38M | 114.20% |
Free cash flow | 55.45M | 213.00% |
About
Founded
2009
Headquarters
Website
Employees
708
